首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Advanced Stage at Presentation Remains a Major Factor Contributing to Breast Cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country
【2h】

Advanced Stage at Presentation Remains a Major Factor Contributing to Breast Cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country

机译:演讲的高级阶段仍然是造成中等收入国家公立和私立医院之间乳腺癌生存差异的主要因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Survival disparities in cancer are known to occur between public and private hospitals. We compared breast cancer presentation, treatment and survival between a public academic hospital and a private hospital in a middle-income country. Methods: The demographics, clinical characteristics, treatment and overall survival (OS) of 2767 patients with invasive breast carcinoma diagnosed between 2001 and 2011 in the public hospital were compared with 1199 patients from the private hospital. Results: Compared to patients in the private hospital, patients from the public hospital were older at presentation, and had more advanced cancer stages. They were also more likely to receive mastectomy and chemotherapy but less radiotherapy. The five-year OS in public patients was significantly lower than in private patients (71.6% vs. 86.8%). This difference was largely attributed to discrepancies in stage at diagnosis and, although to a much smaller extent, to demographic differences and treatment disparities. Even following adjustment for these factors, patients in the public hospital remained at increased risk of mortality compared to their counterparts in the private hospital (Hazard Ratio: 1.59; 95% Confidence Interval: 1.36–1.85). Conclusion: Late stage at diagnosis appears to be a major contributing factor explaining the breast cancer survival disparity between public and private patients in this middle-income setting.
机译:背景:公立医院和私立医院之间存在癌症的生存差异。我们比较了中等收入国家的公立学术医院和私立医院之间的乳腺癌表现,治疗和生存率。方法:比较2001年至2011年在公立医院确诊的2767例浸润性乳腺癌患者的人口统计学,临床特征,治疗和总生存(OS)与私立医院的1199例患者进行比较。结果:与私立医院的患者相比,公立医院的患者在诊治时年龄更大,癌症晚期。他们也更有可能接受乳房切除术和化学疗法,但放疗较少。公立患者的五年OS显着低于私立患者(71.6%比86.8%)。这种差异主要归因于诊断阶段的差异,尽管程度较小,但归因于人口统计学差异和治疗差异。即使对这些因素进行了调整,公立医院的患者与私立医院的患者相比仍然有更高的死亡风险(危险比:1.59; 95%置信区间:1.36-1.85)。结论:诊断的晚期似乎是解释在这种中等收入环境下公共和私人患者之间乳腺癌生存差异的主要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号